Treatment of small cell carcinoma of the
โ
Nixon, Daniel W.
๐
Article
๐
1984
๐
John Wiley and Sons
๐
English
โ 282 KB
The COPP regimen (cyclophosphamide, Oncovin, procarbazine, prednisone) was one of the first chemotherapy programs to prolong survival in small cell lung cancer (SCLC) significantly. Results with this regimen in 50 patients with SCLC show an overall median survival of 10 months. Survival was decrease